Rossi Christina — SEC Form 4 filings
SEC reporting owner CIK 1756941. 18 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2024-03-06 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 10 filings — 29,655 shares, $2,854,731 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 6,495 shares @ $88.80 ($576,756) in Blueprint Medicines Corp, filed 2025-03-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Blueprint Medicines Corp (BPMC) | Chief Operating Officer | 14 | — | 19 legs · 29,655 sh · $2,854,731 | 16 |
| CG Oncology, Inc. (CGON) | Director | 2 | — | — | 2 |
| Xilio Therapeutics, Inc. (XLO) | Director | 2 | — | — | 2 |
Form 4 filings — Rossi Christina
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | CG Oncology, Inc. (CGON) | Grant/award (A): 9,354 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | CG Oncology, Inc. (CGON) | Grant/award (A): 20,889 (derivative) @ $0 | EDGAR |
| 2025-07-21 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 39,456 · Disposition to issuer (D): 82,374 · Code (U): 20,628 · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 6,500 (derivative) · Disposition to issuer (D): 28,500 (derivative) · +5 more | EDGAR |
| 2025-07-08 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 1,172 @ $128.25 | EDGAR |
| 2025-06-12 | 4 | Xilio Therapeutics, Inc. (XLO) | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 804 @ $100.14 · Sale (S): 1,413 @ $100.67 · Sale (S): 57 @ $101.72 | EDGAR |
| 2025-05-07 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 607 @ $100.97 · Sale (S): 1,343 @ $101.77 · Sale (S): 180 @ $102.82 · Sale (S): 144 @ $103.56 | EDGAR |
| 2025-03-26 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 2,274 @ $95.02 | EDGAR |
| 2025-03-07 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 6,495 @ $88.80 | EDGAR |
| 2025-03-04 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 13,200 @ $0 · Grant/award (A): 26,400 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 2,274 @ $95.14 | EDGAR |
| 2025-01-23 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 529 @ $108.99 · Sale (S): 816 @ $110 · Sale (S): 808 @ $110.78 · Sale (S): 121 @ $111.81 | EDGAR |
| 2024-12-20 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 2,166 @ $95.88 · Sale (S): 108 @ $96.50 | EDGAR |
| 2024-12-02 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 2,274 @ $95.10 | EDGAR |
| 2024-07-08 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 9,625 @ $0 | EDGAR |
| 2024-06-17 | 4 | Xilio Therapeutics, Inc. (XLO) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 6,070 @ $90.69 | EDGAR |
| 2024-03-06 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 15,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1756941 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →